Physician profile
Dimple Agarwal
NPI 1275632887
$16,438.24
in general payments reported to CMS, 2019-2025
59 companies · $2,276 in 2025
The $2,276 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,763 · 2020: $1,992 · 2021: $4,166 · 2022: $1,740 · 2023: $2,499 · 2024: $2,002 · 2025: $2,276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,710 · Education: $66.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,710.33 |
| Education | $66.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,936.62 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $1,361.17 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $1,173.85 | 2019-2025 | Xarelto, Spravato |
| Novo Nordisk INC | $1,114.61 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $1,069.51 | 2019-2025 | Repatha, Otezla, Otezla |
| Abbvie INC. | $1,064.80 | 2020-2025 | Ubrelvy, Qulipta, Botox |
| Glaxosmithkline, LLC. | $1,016.13 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $724.07 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Mylan Specialty L.P. | $645.30 | 2019-2024 | Yupelri |
| Sanofi-Aventis U.S. LLC | $484.71 | 2019-2022 | |
| Allergan, INC. | $400.13 | 2019-2020 | |
| Alkermes, INC. | $393.67 | 2019-2025 | Vivitrol, Vivitrol |
| Novartis Pharmaceuticals Corporation | $345.41 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $344.94 | 2019-2023 | Verquvo, Steglatro, Belsomra |
| Amarin Pharma, INC. | $298.38 | 2020-2021 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $281.87 | 2021-2025 | Austedo Xr, Austedo Xr |
| Scilex Pharmaceuticals INC. | $278.53 | 2019-2023 | Ztlido |
| Bayer Healthcare Pharmaceuticals INC. | $268.11 | 2022-2025 | |
| Pfizer INC. | $254.83 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $200.11 | 2022-2024 | Rexulti |
| Nevro Corp. | $193.87 | 2021-2022 | |
| Dexcom, INC. | $160.72 | 2019-2024 | Dexcom G6 Transmitter |
| Aadi Bioscience, INC. | $149.46 | 2024 | Fyarro |
| E.R. Squibb & Sons, L.L.C. | $149.12 | 2022-2023 | Camzyos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.25 | 2022-2025 | Xifaxan |
| Viatris Specialty LLC | $137.99 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.10 | 2019-2025 | Jardiance |
| Daiichi Sankyo INC. | $124.99 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $124.71 | 2025 | Uptravi, Opsumit |
| Axsome Therapeutics, INC. | $121.93 | 2025 | Symbravo |
| Astellas Pharma US INC | $121.87 | 2021-2023 | Veozah |
| Gilead Sciences, INC. | $112.73 | 2019-2025 | |
| Philips North America LLC | $105.17 | 2022-2025 | Respiratory, Vest Therapy Und, Encore |
| Baxter Healthcare | $100.19 | 2025 | Hillrom - Volara System, Hillrom - Monarch Airway Clearance System |
| Corcept Therapeutics | $85.19 | 2025 | Korlym |
| Abbott Laboratories | $58.30 | 2021-2024 | Freestyle Libre 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.04 | 2023 | Lifevest |
| Kowa Pharmaceuticals America, INC. | $55.87 | 2022-2024 | Zoryve |
| Idorsia Pharmaceuticals US INC | $55.37 | 2023-2024 | Quviviq |
| Grifols USA, LLC | $55.06 | 2024 | Prolastin-C Liquid |
| Boston Scientific Corporation | $52.27 | 2025 | Wavewriter Alpha Prime 16 |
| Caris Mpi, INC. | $50.17 | 2025 | Mi Cancer Seek |
| Therapeuticsmd, INC. | $42.21 | 2020-2021 | |
| Exact Sciences Corporation | $37.97 | 2023 | Cologuard Collection Kit |
| Sun Pharmaceutical Industries INC. | $35.62 | 2020-2021 | |
| Verona Pharma, INC. | $34.49 | 2025 | Ohtuvayre |
| Medtronic, INC. | $27.44 | 2021 | |
| Eisai INC. | $24.76 | 2021 | |
| Xeris Pharmaceuticals, INC. | $24.44 | 2024 | Gvoke Hypopen |
| Esperion Therapeutics, INC. | $24.34 | 2021 | |
| Ferring Pharmaceuticals INC. | $23.39 | 2025 | Rebyota |
| Ironwood Pharmaceuticals, INC | $22.39 | 2022 | |
| Si-Bone, INC. | $22.01 | 2022 | |
| Hologic Sales and Service, LLC | $21.60 | 2023 | Aptima |
| Kyowa Kirin, INC. | $20.70 | 2023 | Crysvita |
| Sunovion Pharmaceuticals INC. | $18.97 | 2019 | |
| Seqirus USA INC | $17.99 | 2022 | |
| Itamar Medical INC | $17.90 | 2025 | Watchpatone |
| Sanofi Pasteur INC. | $16.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dimple Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.